Search

Home > New FDA Approvals > 105 – Tofacitinib dosing for ulcerative colitis, Sarepta’s second Duchenne drug; House to vote on 'right to try' drug bill
Podcast: New FDA Approvals
Episode:

105 – Tofacitinib dosing for ulcerative colitis, Sarepta’s second Duchenne drug; House to vote on 'right to try' drug bill
Category: Science & Medicine
Duration: 00:06:21
Publish Date: 2018-03-13 07:00:00
Description:

March 13, 2018 

Please subscribe, rate and review if you like this podcast. Thank you! The podcast website is http://newfdaapprovals.com

1:04 FDA panel backs proposed tofacitinib dosing for ulcerative colitis https://www.pfizer.com/news/press-release/press-release-detail/pfizer_announces_favorable_outcome_of_fda_advisory_committee_meeting_on_xeljanz_tofacitinib_for_moderately_to_severely_active_ulcerative_colitis

2:24 Sarepta to seek FDA approval this year for second Duchenne drug https://www.bizjournals.com/boston/news/2018/03/12/sarepta-to-seek-fda-approval-this-year-for-second.html

4:00 House to vote Tuesday on 'right to try' drug bill http://thehill.com/policy/healthcare/377863-house-to-vote-tuesday-on-right-to-try-drug-bill

Brought to you by Nascent Medical. For assistance with medical writing, please email info@nascentmc.com.

Music credit: freemusicarchive.org/music/MindsEye/Yellow_Taxi/
Total Play: 0